The RAS signaling pathway is shown to cooperate with impaired p53 activity, as KRAS and NRAS mutations are shown to produce AML and AEL phenotypes, respectively, when combined with the loss of p53 activity in mice [67,68]. This evidence concerns the gene TP53 and acute erythroid leukemia.